Finan B, Yang B, Ottaway N, et al
GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)commonly affect bowel movements, though responses vary widely among patients
Model Your Retatrutide Protocol Use our free calculator to visualize your dosing schedule and projected drug levels over time
Further research is needed to validate these findings in larger and more representative populations (e.g., evaluating real-life early PD populations using different symptomatic therapy patterns) and to explore alternative strategies for minimizing the confounding effects of symptomatic treatment adjustments
Inoue, T
However, after GLP-1RAs treatment, the joint structural damage was significantly alleviated and osteophyte formation was reduced (Fig